6505--763-24-3-021-1011 -Lancaster CMOP CLOMIPHENE CITRATE -(VA-24-00076661)
ID: 36C77024Q0369Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/382dbc08b957400289293c1450944157/view
Timeline
    Description

    The Department of Veterans Affairs is seeking qualified vendors to supply Clomiphene Citrate 50mg tablets for delivery to the Lancaster Consolidated Mail Outpatient Pharmacy (CMOP) facility in Texas. The procurement involves a requirement for 480 units of the specified pharmaceutical, with a focus on compliance with the Drug Supply Chain Security Act and other federal regulations. This opportunity is particularly significant as it supports the VA's commitment to ensuring a reliable supply of essential medications for veterans while promoting small business participation in federal contracting. Interested suppliers must submit their quotations, including a signed solicitation cover page, a completed price schedule, a valid State Wholesale Distributor License, and a Buy American Act certificate by September 17, 2024, at 3:00 PM Central Time. For further inquiries, vendors can contact Kelley Cunningham at Kelley.Cunningham@va.gov or call 913-684-0140.

    Point(s) of Contact
    Kelley CunninghamContract Specialist
    (913) 684-0140
    Kelley.Cunningham@va.gov
    Files
    Title
    Posted
    36C77024Q0369_1.docx
    The Department of Veterans Affairs (VA), through the Network Contracting Office 15, plans to procure Clofimehene Citrate tablets for delivery to the Lancaster CMOP facility in Texas. The presolicitation notice outlines the requirement for one pharmaceutical item, specifically 480 units of Clofimehene Citrate 50mg tablets, with a response deadline set for September 17, 2024. The procurement targets small businesses and emphasizes adherence to the Drug Supply Chain Security Act, requiring vendors to submit their state wholesale distributor licensure. Interested suppliers must submit their quotations via email and provide a signed solicitation cover page, a completed price schedule, their state license, and a Buy American Act certificate. This solicitation reflects the VA's ongoing commitment to ensuring a steady supply of pharmaceuticals to meet the needs of Veterans while supporting small business participation in federal contracting opportunities.
    36C77024Q0369.docx
    The document outlines a Request for Proposal (RFP) from the Department of Veterans Affairs for pharmaceutical supplies for the Consolidated Mail Outpatient Pharmacy (CMOP). It details the solicitation number, effective date, and contact information for submission. The acquisition is open to various types of small businesses, including women-owned and service-disabled veteran-owned businesses. Key provisions include specific delivery requirements, invoicing processes, and adherence to Federal Acquisition Regulations. Suppliers must ensure pharmaceutical products comply with shipping regulations (e.g., USPS-capable) and must provide documentation for drug supply chain security compliance. The proposal mandates bar code labeling on products and requires specific National Drug Codes (NDCs). The document emphasizes the importance of quality assurance throughout the procurement process, outlining expectations for product availability, acceptance, and recall notifications. Additionally, it includes clauses that enforce compliance with federal laws related to small business participation and regulations governing government contracts. Overall, this RFP exemplifies the federal government’s commitment to maintaining rigorous standards in procurement while promoting small business involvement.
    S02_Pricing Schedule_Q0369.xlsx
    The CMOP Lancaster RFQ 3677024Q0369 solicits quotes for pharmaceuticals and medical surgical supplies, with a delivery timeline of 10 days after receipt of order. Vendors must submit required documents, including a signed SF1449 cover page, an excel quote spreadsheet, a valid State Wholesale Distributor License, and a Buy American Act (BAA) certificate. The deadline for submissions is September 17, 2024, at 3:00 PM Central Time. Each vendor is limited to one proposal, and if proposing alternate NDCs, they must note any quantity adjustments in their submissions. The requirement mandates that pharmaceutical products must have a minimum shelf life of one year upon delivery, and vendors should specify expiration dates in their comments. The main item listed is Clomiphene Citrate 50mg tablets in a quantity of 480, with detailed documentation on NDCs, manufacturer information, and pricing required. The solicitation underscores the importance of compliance with federal standards and ensures that suppliers can meet urgent government health needs while maintaining quality and safety in pharmaceutical provisioning.
    Similar Opportunities
    6505--S0578 SEVELAMER CARBONATE 800MG TAB (VA-25-00008856)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to procure Sevelamer Carbonate 800mg tablets for delivery to multiple Consolidated Mail Outpatient Pharmacy (CMOP) facilities. The procurement aims to ensure an adequate supply of this essential pharmaceutical, which plays a critical role in the healthcare of veterans, with a total requirement of 8,480 tablets across various locations including Leavenworth, Chelmsford, Tucson, Dallas, Murfreesboro, Great Lakes, and Charleston. Interested parties must submit their quotations by October 31, 2024, including a signed SF1449 cover page, a completed pricing schedule, a valid State Wholesale Distributor License, and a Trade Agreements Act certificate, with all submissions directed to Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov.
    6505--770-25-1-801-0021 -National CMOP DORZOLAMIDE/TIMOLOL -VA-25-00011267)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking to procure DORZOLAMIDE/TIMOLOL ophthalmic solution for its Centralized Mail Order Pharmacy (CMOP) facilities. This procurement involves acquiring quantities ranging from 2,880 to 9,600 units of 10ML packaging, with a focus on ensuring compliance with the Drug Supply Chain Security Act and other regulatory standards. The pharmaceutical products are critical for providing necessary medical care to veterans, reflecting the VA's commitment to delivering high-quality healthcare solutions. Interested vendors must submit their quotations by November 12, 2024, following the release of the solicitation on November 4, 2024, and can direct inquiries to Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov.
    6505--Norethindrone 5mg Tablet (VA-25-00005551)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the supply of Norethindrone Acetate Tablets under Request for Proposal (RFP) 36E79724R0027. The procurement aims to establish contracts for the pharmaceutical product, with specific requirements regarding pricing for a base year and four option years, compliance with packaging standards, and adherence to the Drug Supply Chain Security Act (DSCSA) regulations. This medication is essential for various health treatments within the VA system, ensuring that veterans receive necessary pharmaceutical care. Interested contractors must submit their proposals by November 15, 2024, at 2:30 PM Central Standard Time, to the designated email addresses provided in the solicitation documents. For further inquiries, potential bidders can contact Contracting Officer Adrienne A Albachiara at Adrienne.Albachiara@va.gov.
    6505--Verapamil Hydrochloride (HCL) Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) National Acquisition Center is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0006 to procure Verapamil Hydrochloride (HCL) Tablets. This procurement aims to ensure an uninterrupted supply of the drug for various federal entities, including the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The contract will have a duration of one year, with the potential for four additional one-year options, and the estimated annual requirements include specific dosages and quantities of the tablets. Interested vendors must submit their proposals by December 4, 2024, and are encouraged to check SAM.gov for updates regarding the solicitation. For inquiries, vendors can contact Contract Specialist Deborah Fassl at Deborah.Fassl@va.gov or by phone at 708-786-5894.
    6505--Abiraterone Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0005 to procure Abiraterone Acetate Tablets, an essential medication for various federal health care programs. The procurement aims to secure a reliable supply of 250mg Abiraterone Acetate Tablets, with an estimated annual requirement of 71,997 bottles, to support the VA, Department of Defense, Bureau of Prisons, and other federal entities. This contract will span one base year with four optional one-year extensions, ensuring continuity of supply for critical health services. Interested offerors should monitor sam.gov for the electronic issuance of the solicitation on or about November 22, 2024, with a closing date of December 6, 2024; inquiries can be directed to Richard Mahario at Richard.Mahario@va.gov or by phone at 708-786-5247.
    6509--Warfarin Tablets (VA-25-00012328)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) 36E79725R0007 for the procurement of Warfarin Tablets, aimed at ensuring a reliable supply for various federal health agencies, including the Department of Defense and the Bureau of Prisons. This unrestricted procurement will cover multiple tablet strengths and packaging sizes, with an estimated annual usage detailed across 16 product types, and will be awarded for an initial one-year period with options for four additional years. The successful contractor must provide unique labeling and a National Drug Code (NDC) associated with their product, emphasizing the importance of compliance with federal regulations in pharmaceutical supply. Interested vendors should note that the solicitation will be electronically issued around November 13, 2024, with a response deadline of November 27, 2024; inquiries can be directed to Contract Specialist Adrienne Albachiara at adrienne.albachiara@va.gov.
    6505--770-25-1-801-0019 -National CMOP BUDESONIDE -(VA-25-00010963)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Budesonide 0.5MG/2ML inhalation suspension through the National CMOP program. Vendors are required to submit a signed SF1449 solicitation cover page, a completed quote spreadsheet, evidence of a valid state wholesale distributor license, and a Trade Agreement Act certificate, with all submissions due by November 8, 2024. This pharmaceutical is critical for the treatment of respiratory conditions among veterans, and all products must comply with stringent regulatory standards, including bar-coding and adherence to the Drug Supply Chain Security Act. Interested vendors can contact Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov for further details.
    6505--Aspirin_Dipyridamole SA Capsules (VA-25-00011491)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is soliciting offers for the procurement of Aspirin 25MG/Dipyridamole 200MG Sustained Action Capsules under solicitation number VA-25-00011491. This procurement aims to ensure a reliable supply chain for pharmaceuticals critical to various governmental health agencies, including the Department of Defense and Indian Health Services, and requires offerors to submit pricing for a base year and four option years, along with a Cost Recovery Fee of 0.5%. Compliance with the Drug Supply Chain Security Act (DSCSA) and FDA manufacturing standards is mandatory, and contractors must adhere to stringent packaging and labeling guidelines while demonstrating past performance evaluations. Interested parties should contact Contract Specialist Youlanda Duggar at youlanda.duggar@va.gov for further details.
    6505-- Pegfilgrastim
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Pegfilgrastim, a critical pharmaceutical product, through its Pharmaceutical Prime Vendor (PPV) program. The objective of this solicitation is to establish a reliable supply chain for specified medications at competitive prices, while ensuring compliance with the Drug Supply Chain Security Act (DSCSA) and promoting small business participation. Pegfilgrastim is essential for patients undergoing chemotherapy, as it helps to stimulate the production of white blood cells, thereby reducing the risk of infection. Interested offerors must submit proposals that include unique National Drug Codes (NDCs), pricing for a base year and four optional renewal years, and details on compliance with safety standards. For further inquiries, contact Contract Specialist Matthew S. Poulin at Matthew.Poulin@va.gov.
    6505--Metformin SA Tablets REPACK PROGRAM
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Metformin HCL SA Tablets, aimed at ensuring a consistent supply for various governmental entities, including the VA, Department of Defense, Bureau of Prisons, and others. The procurement will cover a one-year contract with the possibility of four additional one-year extensions, requiring offerors to provide a unique National Drug Code (NDC) number and distinct labeling for the supplied products. This initiative is critical for maintaining the availability of essential pharmaceuticals, with estimated annual requirements detailed for two groups: Other Government Agencies and the VA Repack Program. The solicitation, numbered 36E79725R0003, is scheduled for electronic release on December 3, 2024, with a closing date of December 17, 2024. Interested parties can direct inquiries to Teresa Hussain at teresa.hussain@va.gov or by phone at 708-786-5852, and are encouraged to monitor SAM.gov for updates.